🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSouth Korea Ozempic availability — 12 month update Page 4

South Korea Ozempic availability — 12 month update

greg_boulder Sat, Aug 16, 2025 at 6:58 AM 40 replies 1,750 viewsPage 4 of 8
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Aug 23, 2025 at 8:36 PM#16

Clinical perspective, offered as context rather than as advice. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

26 1nick_newbie, DadBodDave, AmyNC_wife and 23 others
Reply Quote Save Share Report
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Aug 24, 2025 at 4:15 AM#17
rachel_ABQ said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

This is where I part company with the consensus forming above. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

Correct me if the detail matters more than I have assumed.

25 0hyun_seoul, jim_asheville, matt_MKE and 22 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Aug 24, 2025 at 11:55 AM#18
rachel_ABQ said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

rachel_ABQ has the substance of this right. The condition it depends on is worth stating. Albumin binding above 99% is the whole reason weekly dosing works, and it is also why the trough matters more than the peak. People who dose late are not losing a peak, they are letting the trough fall, and the appetite effect tracks the trough.

Correct me if the detail matters more than I have assumed.

24 24MaxMetOK, MounjBrad, nick_newbie and 21 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Aug 24, 2025 at 7:35 PM#19
rachel_ABQ said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

This is exactly what I could not find anywhere else. Taking it to my next appointment.

23 23lori_vegas, Dr.PulmRoch, maya_sedona and 20 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Aug 25, 2025 at 3:15 AM#20

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. Report rather than reply if it drifts again.

1 1PeptideSynthNJ
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register